Steven Michael Picksley

Title: Steven Michael Picksley: Innovator in Cancer Research

Introduction

Steven Michael Picksley is a notable inventor based in Bradford, GB. He has made significant contributions to the field of cancer research, particularly through his innovative work on compounds that target oncogene proteins. His research aims to improve therapeutic treatments for cancer patients.

Latest Patents

Picksley holds a patent for "Inhibitors of the interaction between P53 and MDM2." This invention relates to compounds capable of binding to the oncogene protein MDM2. The patent outlines processes for the preparation of such compounds, pharmaceutical preparations that include these compounds, and their uses in therapeutic treatments. The invention also addresses methods for inhibiting the growth of tumor cells that contain the wild type p53 suppressor by interfering with the interaction between human p53 and human MDM2. He has 1 patent to his name.

Career Highlights

Picksley is associated with Cancer Research Campaign Technology Limited, where he continues to advance his research in cancer therapeutics. His work is pivotal in developing new strategies for cancer treatment, focusing on the molecular interactions that contribute to tumor growth.

Collaborations

Throughout his career, Picksley has collaborated with esteemed colleagues such as Carlos Garcia-Echeverria and Patrick Chène. These collaborations have further enriched his research and contributed to the advancement of cancer therapies.

Conclusion

Steven Michael Picksley is a dedicated inventor whose work in cancer research has the potential to significantly impact therapeutic approaches. His innovative patents and collaborations highlight his commitment to improving treatment options for cancer patients.